• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CPT
Click for more information
0.00% 4.0¢

CIPHERPOINT LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CPT
shorting 		13/12/12 0 924
13/12/12 Last post  rodreso Comments Created with Sketch.  0  Views Created with Sketch.  924 
CPT
this is not the right thread for coalspur talk 		22/02/12 0 629
22/02/12 Last post  Cialis Comments Created with Sketch.  0  Views Created with Sketch.  629 
CPT
hinton parklander 		18/02/12 0 578
18/02/12 Last post  GRH123 Comments Created with Sketch.  0  Views Created with Sketch.  578 
CPT
coalspur will not go for less than 5.00 		15:40 0 590
15:40 Last post  dangerboy61 Comments Created with Sketch.  0  Views Created with Sketch.  590 
CPT
cyclops questions re ann 		04/11/10 0 431
04/11/10 Last post  banksy88 Comments Created with Sketch.  0  Views Created with Sketch.  431 

See All Discussions arrow Created with Sketch.

Top Stories

HotCopper Highlights: Your most watched stocks for Week 46, 2024

What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.